August 2014

Ryogen Awarded Two U.S. Patents Directed to Hepatitis C and Diabetes

New Patents Further Develop IP Related to CD81 and Human Glucokinase

Suffern, N.Y. –August 27, 2014 – Ryogen LLC, an R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded two new patents, bringing the total number of its issued U.S. Patents to 34. 

U.S. Patent No. 8,795,959 titled “Isolated glucokinase genomic polynucleotide fragments from chromosome 7” was issued August 5, 2014. This patent continues the theme of a previously issued Ryogen patent, U.S. Patent No. 8,313,899. The new patent claims a method of detection of specified sequences from polynucleotide sequence which encodes a protein that has human glucokinase activity. Glucokinase plays an important role in the regulation of carbohydrate metabolism. It serves as a glucose sensor of the insulin-producing pancreatic cells, controls the conversion of glucose to glycogen in the liver, and regulates hepatic glucose production. Mutations in the gene for this enzyme are associated with different forms of Diabetes and Hypoglycemia. 

Push-Up Bra Insert Patent Dispute Raises a Critical Issue

Submitted by patentadmin on Wed, 08/27/2014 - 01:56

Runberg Inc. (that does business as “Zephyrs”) filed a $5.9 million malpractice lawsuit against law firm McDermott Will & Emery LLP claiming that the attorneys’ patent-drafting errors allowed and Victoria’s Secret to infringe its invention for bra push-up inserts. Zephyrs claims that drafting errors rendered U.S. Patent No.

Do You Really Want to Go There?

Submitted by patentadmin on Wed, 08/27/2014 - 01:53

Owner of the Washington Redskins, Pro-Football Inc., filed a lawsuit seeking to overturn the USPTO’s cancellation of its “Redskins” trademark on the grounds that the term is disparaging to Native Americans. The Pro-Football lawsuit claims that the Trademark Office’s decision is “replete with errors of fact and law” and is unconstitutional.